DE60032201D1 - Apoptin bindendes Protein - Google Patents

Apoptin bindendes Protein

Info

Publication number
DE60032201D1
DE60032201D1 DE60032201T DE60032201T DE60032201D1 DE 60032201 D1 DE60032201 D1 DE 60032201D1 DE 60032201 T DE60032201 T DE 60032201T DE 60032201 T DE60032201 T DE 60032201T DE 60032201 D1 DE60032201 D1 DE 60032201D1
Authority
DE
Germany
Prior art keywords
apoptin
binding protein
novel therapeutic
novel
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60032201T
Other languages
English (en)
Other versions
DE60032201T2 (de
Inventor
Mathieu Hubertus Mari Noteborn
Oorschot Astrid Adri Danen-Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leadd BV
Original Assignee
Leadd BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99202858A external-priority patent/EP1081226A1/de
Priority claimed from EP99203465A external-priority patent/EP1108785A1/de
Application filed by Leadd BV filed Critical Leadd BV
Publication of DE60032201D1 publication Critical patent/DE60032201D1/de
Application granted granted Critical
Publication of DE60032201T2 publication Critical patent/DE60032201T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60032201T 1999-09-02 2000-09-01 Apoptin bindendes Protein Expired - Lifetime DE60032201T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP99202858 1999-09-02
EP99202858A EP1081226A1 (de) 1999-09-02 1999-09-02 Apoptin-bindendes Protein
EP99203465 1999-10-21
EP99203465A EP1108785A1 (de) 1999-10-21 1999-10-21 Apoptin-verbundenes Protein

Publications (2)

Publication Number Publication Date
DE60032201D1 true DE60032201D1 (de) 2007-01-18
DE60032201T2 DE60032201T2 (de) 2007-09-20

Family

ID=26153361

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60032201T Expired - Lifetime DE60032201T2 (de) 1999-09-02 2000-09-01 Apoptin bindendes Protein

Country Status (20)

Country Link
US (2) US7317096B1 (de)
EP (1) EP1083224B1 (de)
JP (1) JP2003510030A (de)
CN (1) CN100513565C (de)
AT (1) ATE347597T1 (de)
AU (1) AU781127B2 (de)
BR (1) BR0013743A (de)
CA (1) CA2383784A1 (de)
CY (1) CY1106355T1 (de)
DE (1) DE60032201T2 (de)
DK (1) DK1083224T3 (de)
EA (1) EA005933B1 (de)
ES (1) ES2277815T3 (de)
HU (1) HUP0202688A2 (de)
IL (2) IL148469A0 (de)
NO (1) NO20021067L (de)
NZ (1) NZ517740A (de)
PL (1) PL204275B1 (de)
PT (1) PT1083224E (de)
WO (1) WO2001016165A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7256274B2 (en) * 1999-12-10 2007-08-14 Leadd B.V. Apoptin-associating protein
ES2525065T3 (es) 2008-04-11 2014-12-17 Merrimack Pharmaceuticals, Inc. Ligadores de seroalbúmina humana y sus conjugados
WO2011100428A2 (en) * 2010-02-10 2011-08-18 The Uab Research Foundation Compositions for improving bone mass

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
CA2208237C (en) 1994-12-22 2009-04-14 Novartis Ag Nuclear protein serine/threonine kinases
ATE241808T1 (de) * 1995-06-07 2003-06-15 Leadd Bv Verwendungen von apoptin
WO1998039448A2 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
SK286235B6 (sk) * 1997-08-12 2008-06-06 Leadd B. V. Spôsob zisťovania transformačnej schopnosti látky, spôsob zisťovania predispozície buniek stať sa nádorovými bunkami, použitie nukleovej kyseliny a diagnostická súprava
EP0924296A3 (de) * 1997-12-03 2001-08-01 Leadd B.V. Verfahren un Mittteln für die Induktion von Apoptosis durch Interferenz in RNS-Prozessierung
EP0927757A1 (de) * 1997-12-03 1999-07-07 Leadd B.V. Verfahren und Mitteln um Apoptose zu induzieren durch Interferenz mit Bip-ähnliche Proteine
EP0921192A1 (de) * 1997-12-03 1999-06-09 Leadd B.V. Molekulen interagierend mit Apoptin
US20030105315A1 (en) 1998-04-09 2003-06-05 Metagen Pharmaceuticals Gmbh Human nucleic acid sequences from ovarian tumor tissue
EP1075518A2 (de) * 1998-05-05 2001-02-14 Incyte Pharmaceuticals, Inc. Menschlicher transkriptionsregulatormoleküle
US7256274B2 (en) 1999-12-10 2007-08-14 Leadd B.V. Apoptin-associating protein
EP1111045A3 (de) 1999-12-10 2001-09-19 Leadd B.V. Apoptin-bindendes Protein
EP1106691A1 (de) 1999-12-10 2001-06-13 Leadd B.V. Apoptin verbundenes Protein
WO2001053351A2 (en) 2000-01-17 2001-07-26 Leadd B.V. Apoptin bindendes protein
EP1138765A1 (de) 2000-03-27 2001-10-04 Leadd B.V. Apoptin verbundene Proteine AAP-5 und AAP-6

Also Published As

Publication number Publication date
PL204275B1 (pl) 2009-12-31
WO2001016165A2 (en) 2001-03-08
NZ517740A (en) 2003-09-26
PL354285A1 (en) 2003-12-29
US7317096B1 (en) 2008-01-08
CN100513565C (zh) 2009-07-15
EA005933B1 (ru) 2005-08-25
US20080176231A1 (en) 2008-07-24
US7767790B2 (en) 2010-08-03
ATE347597T1 (de) 2006-12-15
JP2003510030A (ja) 2003-03-18
NO20021067D0 (no) 2002-03-04
EA200200321A1 (ru) 2002-08-29
AU781127B2 (en) 2005-05-05
DK1083224T3 (da) 2007-04-10
CY1106355T1 (el) 2011-10-12
WO2001016165A3 (en) 2001-09-20
IL148469A (en) 2009-02-11
DE60032201T2 (de) 2007-09-20
ES2277815T3 (es) 2007-08-01
IL148469A0 (en) 2002-09-12
EP1083224A2 (de) 2001-03-14
AU7324200A (en) 2001-03-26
BR0013743A (pt) 2005-01-11
PT1083224E (pt) 2007-03-30
HUP0202688A2 (en) 2002-12-28
EP1083224A3 (de) 2001-04-25
EP1083224B1 (de) 2006-12-06
NO20021067L (no) 2002-05-02
CA2383784A1 (en) 2001-03-08
CN1387569A (zh) 2002-12-25

Similar Documents

Publication Publication Date Title
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
WO2002057303A3 (en) Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides
DE60215848D1 (de) 1,2,4-thiadiazolverbindungen als melanocortinrezeptor-modulatoren
DE69433406T2 (de) Antikörper gegen cd40
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
DE60103351D1 (de) Zusammensetzung zur Bekämpfung von Ektoparasiten
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
DK1313762T3 (da) Suppressor-gen
DK1536778T3 (da) Proteiner, der binder til cross-beta-strukturholdigt amyloid og fremgangsmåder til modulation af cross-beta-strukturen, dens dannelse og dens associerede toksicitet
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
ATE299183T1 (de) Apoptose induzierende proteinesubstanz
ATA9592000A (de) Betätigungsanordnung für schwenkbare teile von verdecken
ATE347597T1 (de) Apoptin bindendes protein
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
WO2001072825A3 (en) Apoptin-associating protein
DK1387854T3 (da) SFRP og peptidmotiver som interagerer med SFRP og fremgangsmåder til anvendelse deraf
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DE60038955D1 (de) AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47
WO2001042461A3 (en) Apoptin-associating protein
EP1111045A3 (de) Apoptin-bindendes Protein
WO2001053351A3 (en) Apoptin bindendes protein
EP1138768A3 (de) Apoptin-bindendes Protein AAP-5
EP1118662A3 (de) Apoptin bindendes Protein
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
MXPA03007990A (es) Uso de la proteina histidina fosfatasa.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition